Alignment Healthcare/$ALHC
1D1W1MYTD1Y5YMAX
Capital at risk
About Alignment Healthcare
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
- Ticker
- $ALHC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 1,849
- Headquarters
- Orange, United States
- Website
- www.alignmenthealth.com
ALHC Metrics
BasicAdvanced
$2.6B
64.58
$0.20
1.11
-
Price and volume
Market cap
$2.6B
Beta
1.11
52-week high
$25.12
52-week low
$12.65
Average daily volume
5.4M
Financial strength
Current ratio
1.698
Quick ratio
1.461
Long term debt to equity
124.655
Total debt to equity
124.655
Interest coverage (TTM)
3.44%
Profitability
EBITDA (TTM)
87.417
Gross margin (TTM)
12.55%
Net profit margin (TTM)
0.89%
Operating margin (TTM)
1.22%
Effective tax rate (TTM)
-4.99%
Revenue per employee (TTM)
$2,480,000
Management effectiveness
Return on assets (TTM)
3.06%
Return on equity (TTM)
20.04%
Valuation
Price to earnings (TTM)
64.575
Price to revenue (TTM)
0.567
Price to book
9.97
Price to tangible book (TTM)
11.57
Price to free cash flow (TTM)
14.608
Free cash flow yield (TTM)
6.85%
Free cash flow per share (TTM)
0.874
Growth
Revenue change (TTM)
37.21%
Earnings per share change (TTM)
-174.07%
3-year revenue growth (CAGR)
41.27%
3-year earnings per share growth (CAGR)
-39.40%
What the Analysts think about ALHC
Analyst ratings (Buy, Hold, Sell) for Alignment Healthcare stock.
Analyst projections of the future price of Alignment Healthcare stock.
Bulls say / Bears say
Total revenue grew 31.6% year-over-year to $1.3 billion in Q2 2026, surpassing the high end of guidance and demonstrating robust top-line execution (GlobeNewswire)
Medicare Advantage membership increased 31.5% year-over-year to approximately 294,100 members, underscoring strong consumer demand and expansion in core markets (GlobeNewswire)
Management raised the midpoint of full-year guidance across membership, revenue, adjusted gross profit, and adjusted EBITDA, reflecting confidence in sustained growth trajectory (MarketBeat)
Shares plunged up to 19% after a whistleblower lawsuit was reported, alleging manipulation of financials to inflate stock price, raising governance concerns (Bloomberg Law)
A surge in high-acuity C-SNP and D-SNP membership in Q2 2026 introduces near-term claims cost risk ahead of corresponding risk-adjusted revenue, potentially pressuring margins (Actuary.info)
Funded leverage ratio increased to 2.2× trailing 12-month EBITDA at Q2 end, potentially limiting financial flexibility and increasing vulnerability to interest rate fluctuations (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 27 Aug 2026.
ALHC Financial Performance
Revenues and expenses
ALHC Earnings Performance
Company profitability
Upcoming events
No upcoming events
ALHC News
AllArticlesVideos
Kaplan Fox Reminds Alignment Healthcare, Inc. (ALHC) Investors of an Investigation into Potential Securities Law Violations
Newsfile Corp2 days ago
Kaplan Fox & Kilsheimer LLP Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations
Newsfile Corp3 days ago
Kaplan Fox is Investigating Alignment Healthcare, Inc. (ALHC) on Behalf of Investors for Potential Securities Law Violations
Newsfile Corp7 days ago
Funds containing ALHC
AllEURUSDGBP
Fund name | Fund size | $ALHC weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.18% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.09% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.09% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.09% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.